SSABB:FTSEFTSE AbbVie Index Analysis

SSAB AB (publ) trades at €6.93, sitting below its 20‑day (7.14) and 50‑day (7.08) simple moving averages, while still above the 200‑day average (5.78), indicating a short‑term pullback within a longer‑term uptrend. The RSI of 46.7 suggests neutral momentum, and the MACD histogram is negative with a bearish signal line, reinforcing the near‑term downside bias. Volume has been trending lower, and the stock is approaching its technical support at €6.45, making the next few sessions critical. Volatility is elevated at roughly 47% over the past 30 days, but the computed beta of 0.34 points to limited sensitivity to broader market swings. The fear‑and‑greed index sits at 77.25, signaling market optimism despite the technical softness.
Fundamentally, the company appears markedly cheap on a price‑to‑book basis (0.10×) and offers a solid 2.67% dividend yield, though free cash flow is negative and revenue is contracting (-6.4%). The PE of 15 is modest, but the high debt‑to‑equity ratio (≈16.7) and modest ROE (7%) raise concerns about capital efficiency. Given the low beta and a diversified geographic footprint, sector‑specific risks are tempered, yet steel’s exposure to carbon‑intensity regulations adds a medium regulatory head‑wind. Overall, the stock sits in a value‑oriented sweet spot with attractive yield but faces short‑term pressure and longer‑term execution challenges.